AI-Ready unified platform for life sciences manufacturing combining MES, LIMS, ELN, and Scheduling in a single integrated system with Electronic Batch Records, Master Batch Records, and comprehensive GxP compliance for pharmaceutical and biotech manufacturing.
L7|ESP (Enterprise Science Platform) is a unified, AI-ready platform designed specifically for life sciences manufacturing operations. The platform integrates MES (Manufacturing Execution System), LIMS (Laboratory Information Management System), ELN (Electronic Lab Notebook), and Scheduling capabilities into a single cohesive system with a unified data model.
The L7 MES component provides comprehensive manufacturing execution capabilities including Electronic Batch Records (EBR), Master Batch Records, Recipe Management, Bill of Materials, Sample Plan Management, Quality Review, and configurable e-signature workflows. The platform supports label reconciliation, automatic batch report generation, and maintains full Chain of Identity (CoI) and Chain of Custody (CoC) tracking throughout the manufacturing process.
The unified platform architecture eliminates data silos between manufacturing, quality, and laboratory operations. The platform also provides bi-directional SAP integration and process equipment integration capabilities. The platform provides data trending and charting tools for both single-batch and cross-batch analysis, enabling process optimization and deviation investigation.
L7|ESP is designed for FDA 21 CFR Part 11 compliance and GxP-regulated pharmaceutical manufacturing environments. Named customers and case studies centre on cell & gene therapy manufacturing, biotech, and CDMO operations. Case studies demonstrate tangible benefits including 30% reduction in data handling time for contract manufacturing organizations.
Customers span biotech and pharmaceutical manufacturers with 50–500 employees, particularly those in cell & gene therapy, personalised medicine, and contract manufacturing. Named customers include Gradalis, Cellipont Bioservices, Cellares, QIAGEN, GeneDx, Dana-Farber Cancer Institute, and Vernal Biosciences.
Pharmaceutical Edition
L7|ESP is built exclusively for life sciences with 100% focus on pharmaceutical, biotech, and cell & gene therapy manufacturing
Core Capabilities
FDA & GxP Compliance
Data Integrity & Validation
L7|ESP is a cloud-based unified platform with integrated MES, LIMS, ELN, and Scheduling capabilities. The platform features a unified data model that eliminates data silos between manufacturing, quality, and laboratory operations.
Integration capabilities include bi-directional SAP integration for enterprise data synchronization, process equipment integration for real-time manufacturing data capture, and instrument connectors for automated data acquisition from laboratory and manufacturing equipment. The platform supports REST API for custom integrations.
The unified architecture enables data flow between Electronic Batch Records, sample management, and laboratory workflows. AI-ready platform design supports future machine learning and predictive analytics capabilities.
L7|ESP pricing is not publicly disclosed and follows an enterprise pricing model based on organization size, number of users, and module configuration. Pricing is available by contacting sales.
The platform uses a subscription-based licensing model. Implementation services, validation support, and ongoing platform updates are included in the subscription. Product demos are available on request.
Typical deal size and per-user pricing are not publicly disclosed. Free trial availability is undisclosed.
L7|ESP implementation includes platform configuration, workflow setup, SAP integration (if applicable), equipment integration, and validation support for GxP environments. Typical implementation timeline is 6-9 months for mid-sized biotech/pharma organizations.
The platform is designed for configurable workflows without extensive custom development. Case studies show 30% reduction in data handling time for CDMO implementations. Validation documentation and support is provided for FDA-regulated environments.
Migration from legacy systems includes data migration tools and transition planning. The cloud-based deployment model reduces infrastructure requirements and accelerates time to value.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
Unified platform eliminates data silos between MES, LIMS, and ELN. Integration with SAP and manufacturing equipment. Life sciences-specific platform design. Case studies demonstrate measurable time savings (30% reduction in data handling). Customer base concentrated in cell & gene therapy manufacturing.
Limitations & Open Questions
Limited public reviews available for independent validation. Pricing not transparent. Implementation timeline of 6-9 months may be lengthy for some organizations. Platform requires significant configuration for complex workflows.
Help the community
Share your experience with L7|ESP anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section